# OnCo record mgn-3-rice-bran-arabinoxylan (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/mgn-3-rice-bran-arabinoxylan/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "mgn-3-rice-bran-arabinoxylan" ;
  schema:name "MGN-3 (rice bran arabinoxylan, BioBran)"@en ;
  schema:alternateName "Rice bran arabinoxylan compound"@en, "BioBran"@en ;
  schema:description "MGN-3 is a rice bran product treated with mushroom enzymes and promoted as an immune booster against cancer. A few small, short studies report immune changes and fewer treatment side effects, which is not enough to say it helps. No side effects or interactions have been reported."@en ;
  schema:url <https://onco.cc/technologies/mgn-3-rice-bran-arabinoxylan/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.mskcc.org/cancer-care/integrative-medicine/herbs/mgn-3> ;
  onco:status "phase-2" ;
  onco:tag "complementary", "supportive-care", "evidence:insufficient" ;
  onco:related <https://onco.cc/technologies/agaricus-blazei/>, <https://onco.cc/technologies/ahcc-shiitake-extract/> ;
  onco:sections <https://onco.cc/fronts/supportive-care/>, <https://onco.cc/fronts/nutrition-lifestyle/> ;
  onco:technologies <https://onco.cc/technologies/integrative-oncology/>, <https://onco.cc/technologies/dietary-supplements-treatment-interactions/> ;
  onco:drugs <https://onco.cc/drugs/cisplatin/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-misinformation/> .
